SCHEDULE 13D

Company

BIOCRYST PHARMACEUTICALS INC

Filed

July 1, 2002

Accession Number

0000912057-02-026112

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →